Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F16%3A10331028" target="_blank" >RIV/00179906:_____/16:10331028 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11150/16:10331028

Výsledek na webu

<a href="http://dx.doi.org/10.1530/EDM-15-0138" target="_blank" >http://dx.doi.org/10.1530/EDM-15-0138</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1530/EDM-15-0138" target="_blank" >10.1530/EDM-15-0138</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?

Popis výsledku v původním jazyce

Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60 years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and often not recommended. In accordance with European consensus, and contrary to the American Thyroid Association (ATA) guidelines, we recently performed RAI thyroid remnant ablation in a patient with differentiated papillary multifocal microcarcinoma. The post-therapeutic whole-body scan and SPECT/CT revealed the real and unexpected extent of disease, with metastases to upper mediastinal lymph nodes. This finding led to the patient's upstaging from stage I to stage IVa according to the American Joint Committee on Cancer/International Union Against Cancer criteria.

Název v anglickém jazyce

Is radioiodine administration in patients with papillary thyroid multifocal microcarcinoma unnecessary?

Popis výsledku anglicky

Radioiodine (RAI) has played a crucial role in differentiated thyroid cancer treatment for more than 60 years. However, the use of RAI administration in patients with papillary thyroid microcarcinoma (even multifocal) is now being widely discussed and often not recommended. In accordance with European consensus, and contrary to the American Thyroid Association (ATA) guidelines, we recently performed RAI thyroid remnant ablation in a patient with differentiated papillary multifocal microcarcinoma. The post-therapeutic whole-body scan and SPECT/CT revealed the real and unexpected extent of disease, with metastases to upper mediastinal lymph nodes. This finding led to the patient's upstaging from stage I to stage IVa according to the American Joint Committee on Cancer/International Union Against Cancer criteria.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2016

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Endocrinology, Diabetes and Metabolism Case Reports [online]

ISSN

2052-0573

e-ISSN

—

Svazek periodika

Neuvedeno

Číslo periodika v rámci svazku

May

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

4

Strana od-do

—

Kód UT WoS článku

000379346600004

EID výsledku v databázi Scopus

—